Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population

被引:1
|
作者
Brown, AJL
Frost, SDW
Mathews, WC
Dawson, K
Hellmann, NS
Daar, ES
Richman, DD
Little, SJ
机构
[1] Univ Edinburgh, Inst Cell Anim & Populat Biol, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland
[2] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA
[3] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA
[4] ViroLogic, San Francisco, CA USA
[5] Harbor Univ Calif Los Angeles Med Ctr, Torrance, CA USA
[6] Vet Affairs San Diego Healthcare Syst, La Jolla, CA USA
来源
JOURNAL OF INFECTIOUS DISEASES | 2003年 / 187卷 / 04期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although the prevalence of drug-resistant strains in primary human immunodeficiency virus (HIV) infection in North America has recently increased, their transmission fitness remains unknown. The present study estimated the frequency of transmission of drug-resistant HIV from patients receiving antiretroviral therapy using retrospective surveys of clinic data. It revealed that resistant virus was transmitted only similar to20% as frequently as expected from these patients. Individuals with primary resistance may become a significant source of resistant strains.
引用
收藏
页码:683 / 686
页数:4
相关论文
共 50 条
  • [21] Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase
    Boyer, PL
    Sarafianos, SG
    Arnold, E
    Hughes, SH
    JOURNAL OF VIROLOGY, 2001, 75 (10) : 4832 - 4842
  • [22] THE CLINICAL-SIGNIFICANCE OF DRUG-RESISTANT MUTANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS
    RICHMAN, DD
    RESEARCH IN VIROLOGY, 1992, 143 (02): : 130 - 131
  • [23] Quantifying mixed populations of drug-resistant human immunodeficiency virus type 1
    Moser, MJ
    Ruckstuhl, M
    Larsen, CA
    Swearingen, AJ
    Kozlowski, M
    Bassit, L
    Sharma, PL
    Schinazi, RF
    Prudent, JR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) : 3334 - 3340
  • [24] Drug-resistant tubeculosis in Spain. Trends and influence of the human immunodeficiency virus
    Ayuela, PD
    MEDICINA CLINICA, 2001, 117 (02): : 59 - 63
  • [25] Antiretroviral resistance in human immunodeficiency virus infection
    Afani S, Alejandro
    Gallardo O, Ana M.
    REVISTA CHILENA DE INFECTOLOGIA, 2011, 28 (05): : 461 - 469
  • [26] DRUG-RESISTANT TUBERCULOSIS IN AN URBAN-POPULATION INCLUDING PATIENTS AT RISK FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    CHAWLA, PK
    KLAPPER, PJ
    KAMHOLZ, SL
    POLLACK, AH
    HEURICH, AE
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (02): : 280 - 284
  • [27] Drug-resistant human immunodefiency virus
    Kozal, M. J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 : 69 - 73
  • [28] Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance
    Sethi, AK
    Celentano, DD
    Gange, SJ
    Moore, RD
    Gallant, JE
    CLINICAL INFECTIOUS DISEASES, 2003, 37 (08) : 1112 - 1118
  • [29] Antiretroviral therapy and drug resistance in human immunodeficiency virus type 2 infection
    Menendez-Arias, Luis
    Alvarez, Mar
    ANTIVIRAL RESEARCH, 2014, 102 : 70 - 86
  • [30] Prevalence of drug-resistant human immunodeficiency virus type 1 in therapy-naive patients and usefulness of genotype testing
    Ibe, S
    Hotta, N
    Takeo, U
    Tawada, Y
    Mamiya, N
    Yamanaka, K
    Utsumi, M
    Kaneda, T
    MICROBIOLOGY AND IMMUNOLOGY, 2003, 47 (07) : 499 - 505